These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9614002)

  • 1. CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats.
    Wyde PR; Moore-Poveda DK; O'Hara B; Ding WD; Mitsner B; Gilbert BE
    Antiviral Res; 1998 Apr; 38(1):31-42. PubMed ID: 9614002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats.
    Wyde PR; Moore DK; Pimentel DM; Gilbert BE; Nimrod R; Panet A
    Antiviral Res; 1996 Jul; 31(3):173-84. PubMed ID: 8811202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Pimentel DM; Blough HA
    Antiviral Res; 1995 May; 27(1-2):59-69. PubMed ID: 7486959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
    Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
    Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection.
    Wyde PR; Chetty SN; Timmerman P; Gilbert BE; Andries K
    Antiviral Res; 2003 Nov; 60(3):221-31. PubMed ID: 14638398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol.
    Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC
    Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.
    Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
    Van den Berg J; Kwanten L; Roymans D
    Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RFI-641, a potent respiratory syncytial virus inhibitor.
    Huntley CC; Weiss WJ; Gazumyan A; Buklan A; Feld B; Hu W; Jones TR; Murphy T; Nikitenko AA; O'Hara B; Prince G; Quartuccio S; Raifeld YE; Wyde P; O'Connell JF
    Antimicrob Agents Chemother; 2002 Mar; 46(3):841-7. PubMed ID: 11850270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
    Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
    Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
    Wyde PR; Ambrose MW; Meyer HL; Zolinski CL; Gilbert BE
    Antiviral Res; 1990; 14(4-5):215-25. PubMed ID: 1965109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors.
    Feng S; Li C; Chen D; Zheng X; Yun H; Gao L; Shen HC
    Eur J Med Chem; 2017 Sep; 138():1147-1157. PubMed ID: 28772235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.
    Wyde PR; Moore-Poveda DK; De Clercq E; Neyts J; Matsuda A; Minakawa N; Guzman E; Gilbert BE
    Antimicrob Agents Chemother; 2000 May; 44(5):1146-52. PubMed ID: 10770743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
    Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
    J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
    Wyde PR; Ambrose MW; Meyer HL; Gilbert BE
    Antiviral Res; 1990; 14(4-5):237-47. PubMed ID: 1965110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.